Merck Agrees To Disclose Clinical Trial Delays
4 CommentsBy Ed Silverman // January 5th, 2012 // 8:34 am
• Pharma Blog » Archives
Enhance
Merck Settles Shareholder Suit Over Enhance Trial
1 CommentBy Ed Silverman // October 19th, 2011 // 7:38 am
Another Vytorin Trial And Changing Endpoints
4 CommentsBy Ed Silverman // October 18th, 2010 // 8:38 am
Schering-Plough Shareholders Win A Round In Court
7 CommentsBy Ed Silverman // June 23rd, 2010 // 7:58 am
Results Of Merck’s Vytorin Trial Delayed A Year
8 CommentsBy Ed Silverman // January 11th, 2010 // 7:44 am
Whytorin? Merck Cholesterol Pills Face Another Test
3 CommentsBy Ed Silverman // November 10th, 2009 // 8:42 am
Grassley To NIH: Watch Those Academic Conflicts
10 CommentsBy Ed Silverman // October 27th, 2009 // 7:08 am
The Trouble With Merck: One Analyst Turns Sour
29 CommentsBy Ed Silverman // September 10th, 2008 // 10:06 am
Congress Miffed Over Vytorin Report & Consultant
4 CommentsBy Ed Silverman // August 21st, 2008 // 12:40 pm